$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:12am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Application for quotation of securities - RNO
RNO released this announcement to the ASX on 20 December 2021, 11:55. The announcement is not marked as price sensitive, and is 6 page(s) in length and 25.39kb in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Application for quotation of securities - RNO | 20 December 2021, 11:55 |
| Change in substantial holding RD | 20 December 2021, 11:43 |
| Cleansing notice | 20 December 2021, 11:40 |
| Change of Director's Interest Notice MJ | 20 December 2021, 11:34 |
If you were already registered, log in here.
If you were already registered, log in here.